Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMC114/RTV vs LPV/RTV in Treatment-Experienced HIV-1
NCT00110877Phase 3Completed
- Sponsor
- Tibotec
- Start
- Apr 2005
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 26
01
Overview
A Phase 3 trial of darunavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Tibotec. Started Apr 2005; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00110877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00110877.